High-throughput Screenings to Identify Host Receptors for Staphylococcal Adhesins
High-throughput Screenings to Identify Host Receptors for Staphylococcal Adhesins
批准号:
8030791
负责人:
RENATA PASQUALINI
金额:
$8.43万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2012-12-31
关键词:
AdherenceAdhesionsAdhesivesAffectAlternative TherapiesAmericanAnimal ModelAntibiotic ResistanceBacteriaBacterial AdhesinsBindingBiologyBlood CirculationCell Surface ProteinsCell WallCommunicable DiseasesCommunitiesComorbidityCost-Benefit AnalysisDataDiseaseEndocarditisEnvironmentEpidemicEventFamilyFeasibility StudiesGenus staphylococcusGram-Positive BacteriaHealthcare SystemsHospitalsImmunocompromised HostImmunomodulatorsIndividualInfectionInfectious Skin DiseasesInvadedLactococcus lactisLigandsLower respiratory tract structureMediatingMedicalMethodologyMinorMolecularOrganismPathogenesisPathologyPatternPhage DisplayPlayPneumoniaProcessProteinsRecombinantsResearchRoleScreening procedureSepsisSkin TissueSoft Tissue InfectionsStagingStaphylococcal InfectionsStaphylococcus aureusStaphylococcus epidermidisSurfaceSystemTechniquesTechnologyTissuesToxinUnited StatesVaccinationVaccinesVirulence FactorsVirulentWorkbasedesigndisorder preventiondrug developmenthigh throughput screeningmicrobialmortalitymutantnovelpathogenic bacteriareceptortherapeutic targetvaccine development
中文摘要
描述(由申请人提供):葡萄球菌引起广泛的传染病,从相当轻微的皮肤感染到严重的疾病,如败血症、肺炎和心内膜炎。虽然金黄色葡萄球菌是迄今为止毒性最强的一种,但表皮葡萄球菌和卢氏葡萄球菌也被发现可引起严重感染,主要发生在免疫功能低下的个体中。在过去,高毒力金黄色葡萄球菌菌株局限于医院环境,主要影响免疫功能低下的患者或有潜在合并症的个体。不幸的是,最近在社区中出现了类似的菌株,在其他健康个体中造成严重感染。表皮葡萄球菌和葡萄球菌在较小程度上和病理上略有不同,似乎遵循相同的模式。这些菌株中的大多数已经进化成对抗生素具有耐药性,这导致了全球流行病,并给医疗保健系统带来了巨大的负担。因此,研制疫苗或确定治疗这些感染的新型或替代疗法的必要性已成为一项未得到满足的紧迫医疗需求。
英文摘要
DESCRIPTION (provided by applicant): Staphylococci cause a wide spectrum of infectious diseases spanning from rather minor skin infections to serious conditions such as sepsis, pneumonia and endocarditis. Although Staphylococcus aureus is by far the most virulent of species, Staphylococcus epidermidis and Staphylococcus lugdunensis have also been found to cause severe infections mostly in immunocompromised individuals. In the past, highly virulent S. aureus strains were confined to the hospital environment mostly affecting immunocompromised patients or individuals with underlying co-morbidities. Unfortunately, similar strains have recently emerged in the community causing severe infections in otherwise healthy individuals. To a lesser extent and slightly different pathology, Staphylococcus epidermidis and Staphylococcus lugdunensis seem to follow the same pattern. Most of these strains have evolved to be resistant to antibiotics, which resulted in a worldwide epidemic and an enormous burden for the healthcare system. Therefore, the necessity of a vaccine or identification of novel or alternative therapies for the treatment of these infections has become an unmet and pressing medical need.
Despite intense efforts, the molecular mechanism of staphylococcal infections is incompletely understood, but it seemingly involves a large number of virulence factors such as adhesins, toxins and immunomodulators. To date, adhesion to host tissues is considered the foremost stage of infection and plays a vital role in the survival of the invading organism. Most likely, the synthesis of toxins and immunomodulators plays a role later in the disease process and depends on the first step of infection. Hence, proteins responsible for adherence have long been recognized as targets for drug and vaccine development.
In staphylococci, as well as other Gram-positive bacteria, adhesion to host tissues is mostly mediated by a family of cell-wall-anchored (CWA) proteins referred to us microbial surface components recognizing adhesive matrix molecules (MSCRAMMs). These proteins have been shown to a) mediate adherence to host proteins, b) participate in self-aggregation and c) modulate the biology of the ligand protein. Furthermore, MSCRAMMs have been shown to be virulence factors in animal models of infection since a mutant lacking all these molecules fails to cause disease. Vaccination with recombinant MSCRAMMs or inhibition of their functions resulted in significant protection against disease. Based on these observations, it is widely agreed that identification of ligands for MSCRAMMs would contribute to a better understanding of molecular events leading to infection and would help us design effective vaccine or targeted therapeutics for disease prevention and treatment.
To that end, this proposed research aims to establish a high-throughput phage display methodology to identify ligands for MSCRAMMs. This work will also serve as a feasibility study to determine if this technique is suitable for large-scale ligand discovery for bacterial cell surface proteins.
PUBLIC HEALTH RELEVANCE: Staphylococcus aureus is the leading cause of bloodstream, lower respiratory tract, skin and soft tissue infections in the United States with an annual mortality approaching 100,000 Americans lives. Our research aims to better understand staphylococcal infection and to set the grounds for targeted therapies against this disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional Targeting of the Tyrosine Kinase EphA5 in Radiation-resistant Lung Cancer
-
批准号:10407456
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2018
-
负责人:RENATA PASQUALINI
-
依托单位:
High-throughput Screenings to Identify Host Receptors for Staphylococcal Adhesins
-
批准号:8207921
-
项目类别:
-
资助金额:$8.43万
-
财政年份:2011
-
负责人:RENATA PASQUALINI
-
依托单位:
Ligand-Directed Targeting in Prostate Cancer Metastasis
-
批准号:7743204
-
项目类别:
-
资助金额:$24.73万
-
财政年份:2009
-
负责人:RENATA PASQUALINI
-
依托单位:
Targeted Modulation of Angiogenesis by VEGFR Peptidomimetic Antagonists
-
批准号:8078085
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2009
-
负责人:RENATA PASQUALINI
-
依托单位:
Targeted Modulation of Angiogenesis by VEGFR Peptidomimetic Antagonists
-
批准号:8271409
-
项目类别:
-
资助金额:$14.35万
-
财政年份:2009
-
负责人:RENATA PASQUALINI
-
依托单位:
Targeted Modulation of Angiogenesis by VEGFR Peptidomimetic Antagonists
-
批准号:8752696
-
项目类别:
-
资助金额:$23.0万
-
财政年份:2009
-
负责人:RENATA PASQUALINI
-
依托单位:
Targeted Modulation of Angiogenesis by VEGFR Peptidomimetic Antagonists
-
批准号:7844829
-
项目类别:
-
资助金额:$38.91万
-
财政年份:2009
-
负责人:RENATA PASQUALINI
-
依托单位:
Targeted Modulation of Angiogenesis by VEGFR Peptidomimetic Antagonists
-
批准号:7580475
-
项目类别:
-
资助金额:$40.65万
-
财政年份:2009
-
负责人:RENATA PASQUALINI
-
依托单位:
Integration of Vascular Genomics and Proteomics for Diagnosis and Therapy of Canc
-
批准号:7905822
-
项目类别:
-
资助金额:$34.05万
-
财政年份:2008
-
负责人:RENATA PASQUALINI
-
依托单位:
Integration of Vascular Genomics and Proteomics for Diagnosis and Therapy of Canc
-
批准号:7684579
-
项目类别:
-
资助金额:$34.05万
-
财政年份:2008
-
负责人:RENATA PASQUALINI
-
依托单位:
Integration of Vascular Genomics and Proteomics for Diagnosis and Therapy of Canc
-
批准号:7503783
-
项目类别:
-
资助金额:$33.72万
-
财政年份:2008
-
负责人:RENATA PASQUALINI
-
依托单位:
Ligand-Directed Tumor Targeting in Preclinical Models
-
批准号:8052719
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2007
-
负责人:RENATA PASQUALINI
-
依托单位:
Ligand-Directed Tumor Targeting in Preclinical Models
-
批准号:7261038
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:RENATA PASQUALINI
-
依托单位:
Ligand-Directed Tumor Targeting in Preclinical Models
-
批准号:7800279
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:RENATA PASQUALINI
-
依托单位:
Ligand-Directed Tumor Targeting in Preclinical Models
-
批准号:7431597
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:RENATA PASQUALINI
-
依托单位:
Ligand-Directed Tumor Targeting in Preclinical Models
-
批准号:7618558
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:RENATA PASQUALINI
-
依托单位:
Regulatory Roles for Vascular Peptidases in Angiogenesis
-
批准号:7093575
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2005
-
负责人:RENATA PASQUALINI
-
依托单位:
Regulatory Roles for Vascular Peptidases in Angiogenesis
-
批准号:6959318
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2005
-
负责人:RENATA PASQUALINI
-
依托单位:
Regulatory Roles for Vascular Peptidases in Angiogenesis
-
批准号:7472276
-
项目类别:
-
资助金额:$35.56万
-
财政年份:2005
-
负责人:RENATA PASQUALINI
-
依托单位:
Regulatory Roles for Vascular Peptidases in Angiogenesis
-
批准号:7260512
-
项目类别:
-
资助金额:$35.56万
-
财政年份:2005
-
负责人:RENATA PASQUALINI
-
依托单位:
海外基金